Vancouver, British Columbia / TNW-ACCESSWIRE / November 19, 2014, 2014 – Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) is pleased to report that Dr. Raj Attariwala was recently quoted in a TIME Magazine story titled “ Driving While High” by TIME journalist Eliza Gray. Dr. Attariwala is Cannabix Technologies’ Chief Engineer and co-founder of the Cannabix Marijuana Breathalyzer. The author of the story, Eliza Gray, has contributed a series of marijuana related articles for TIME Magazine.
The TIME story, Driving While High, examines and provides thorough insight into the increasing problem of driving while under the influence of marijuana. The article states: “It is no surprise that solving the problem is a priority for public officials, since there is evidence to suggest that driving high is a real danger.”
Furthermore, the article quotes and makes mention of Dr. Attariwala and Cannabix President Kal Mahli: “A retired Canadian police officer (Mahli) and a physician (Attariwala) have teamed up to create a new Breathalyzer that will detect marijuana use in the past two hours, a decent measure of impairment since pot’s effects are usually felt for about two to three hours after use. Co-developer Dr. Raj Attariwala says the technology will get more precise as legalization spurs research.”
For the TIME article please visit cannabixtechnologies.com and the links below.
Link to TIME article: http://time.com/3455621/driving-while-high/
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana. Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions. Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the recent use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous. The device is currently in prototype development and the Company is rapidly developing this technology.
We seek Safe Harbor.
On behalf of the Board of Directors
“Rav Mlait”
CEO
Cannabix Technologies Inc.
For further information, contact the Company’s CEO, Rav Mlait 604-551-7831 email at info@cannabixtechnologies.com
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
Recent Comments